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Coordination, PPQ, APHIS, 4700 River
Road Unit 133, Riverdale, MD 20737–
1231; (301) 851–2237; email:
Colin.Stewart@usda.gov.
SUPPLEMENTARY INFORMATION: On May
28, 2019, we published in the Federal
Register (84 FR 24463, Docket No.
APHIS–2019–0002) a notice of
availability for an environmental
assessment relative to permitting the
release of Aphalara itadori for the
biological control of Japanese, Giant,
and Bohemian knotweeds (Fallopia
japonica, F. sachalinensis, and F. x
bohemica), significant invasive weeds,
within the contiguous United States.
Comments on the notice were
required to be received on or before June
27, 2019. We are reopening the
comment period on Docket No. APHIS–
2019–0002 for an additional 60 days.
This action will allow interested
persons additional time to prepare and
submit comments.
We will also consider all comments
received between June 28, 2019 (the day
after the close of the original comment
period) and the date of this notice.
Done in Washington, DC, this 30th day of
July 2019.
Kevin Shea,
Administrator, Animal and Plant Health
Inspection Service.
[FR Doc. 2019–16581 Filed 8–1–19; 8:45 am]
BILLING CODE 3410–34–P

DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2019–0043]

Availability of an Environmental
Assessment for Field Testing of a
Pseudogymnoascus destructans
Vaccine, Live Raccoon Poxvirus
Vector (RCN–CAL/SP)
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice.
AGENCY:

We are advising the public
that the Animal and Plant Health
Inspection Service has prepared an
environmental assessment concerning
authorization to ship for the purpose of
field testing, and then to field test, an
unlicensed Pseudogymnoascus
destructans Vaccine, Live Raccoon
Poxvirus Vector (RCN–CAL/SP). The
environmental assessment, which is
based on a risk analysis prepared to
assess the risks associated with the field
testing of this vaccine, examines the
potential effects that field testing this
veterinary vaccine could have on the
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quality of the human environment.
Based on the risk analysis, we have
reached a preliminary determination
that field testing this veterinary vaccine
will not have a significant impact on the
quality of the human environment, and
that an environmental impact statement
need not be prepared. We intend to
authorize shipment of this vaccine for
field testing following the close of the
comment period for this notice unless
new substantial issues bearing on the
effects of this action are brought to our
attention. We also intend to issue a U.S.
Veterinary Biological Product license for
this vaccine, provided the field test data
support the conclusions of the
environmental assessment and the
issuance of a finding of no significant
impact and the product meets all other
requirements for licensing.
DATES: We will consider all comments
that we receive on or before September
3, 2019.
ADDRESSES: You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
http://www.regulations.gov/#!docket
Detail;D=APHIS-2019-0043.
• Postal Mail/Commercial Delivery:
Send your comment to Docket No.
APHIS–2019–0043, Regulatory Analysis
and Development, PPD, APHIS, Station
3A–03.8, 4700 River Road Unit 118,
Riverdale, MD 20737–1238.
Supporting documents and any
comments we receive on this docket
may be viewed at http://
www.regulations.gov/#!docketDetail;
D=APHIS-2019-0043 or in our reading
room, which is located in Room 1141 of
the USDA South Building, 14th Street
and Independence Avenue SW,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 7997039 before coming.
FOR FURTHER INFORMATION CONTACT: Dr.
Barbara J. Sheppard, Senior Staff
Veterinary Medical Officer, Center for
Veterinary Biologics, Policy, Evaluation,
and Licensing, VS, APHIS, 1920 Dayton
Avenue, Ames, IA 50010; phone (515)
337–6100; fax (515) 337–6120.
For information regarding the
environmental assessment or the risk
analysis, or to request a copy of the
environmental assessment (as well as
the risk analysis with confidential
business information removed), contact
Dr. Mathew Erdman, Senior Staff
Veterinary Medical Officer, Center for
Veterinary Biologics, Policy, Evaluation,
and Licensing VS, APHIS, 1920 Dayton
Avenue, P.O. Box 844, Ames, IA 50010;
phone (515) 337–6100, fax (515) 337–
6120.
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Under the
Virus-Serum-Toxin Act (21 U.S.C. 151
et seq.), a veterinary biological product
must be shown to be pure, safe, potent,
and efficacious before a veterinary
biological product license may be
issued. A field test is generally
necessary to satisfy prelicensing
requirements for veterinary biological
products. Prior to conducting a field test
on an unlicensed product, an applicant
must obtain approval from the Animal
and Plant Health Inspection Service
(APHIS), as well as obtain APHIS’
authorization to ship the product for
field testing.
To determine whether to authorize
shipment and grant approval for the
field testing of the unlicensed product
referenced in this notice, APHIS
conducted a risk analysis to assess the
potential effects of this product on the
safety of animals, public health, and the
environment. Based on the risk analysis,
APHIS has prepared an environmental
assessment (EA) concerning the field
testing of the following unlicensed
veterinary biological product:
Requester: U.S. Geological Survey,
National Wildlife Health Center.
Product: Pseudogymnoascus
destructans Vaccine, Live Raccoon
Poxvirus Vector (RCN–CAL/SP).
Possible Field Test Locations:
Colorado, Iowa, Minnesota, Nebraska,
Oklahoma, Texas, or Wisconsin, among
others.
The above-mentioned product
consists of a live recombinant raccoon
poxvirus vector expressing two
Pseudogymnoascus destructans
proteins. The vaccine is for the oral
vaccination of bats as an aid in the
prevention and control of White-Nose
Syndrome.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provisions
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
Unless substantial issues with adverse
environmental impacts are raised in
response to this notice, APHIS intends
to issue a finding of no significant
impact (FONSI) based on the EA and
authorize shipment of the above product
for the initiation of field tests following
the close of the comment period for this
notice.
Because the issues raised by field
testing and by issuance of a license are
identical, APHIS has concluded that the
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EA that is generated for field testing
would also be applicable to the
proposed licensing action. Provided that
the field test data support the
conclusions of the original EA and the
issuance of a FONSI, APHIS does not
intend to issue a separate EA and FONSI
to support the issuance of the product
license, and would determine that an
environmental impact statement need
not be prepared. APHIS intends to issue
a veterinary biological product license
for this vaccine following completion of
the field test provided no adverse
impacts on the human environment are
identified and provided the product
meets all other requirements for
licensing.
Authority: 21 U.S.C. 151–159; 7 CFR 2.22,
2.80, and 371.4.
Done in Washington, DC, this 30th day of
July 2019.
Kevin Shea,
Administrator, Animal and Plant Health
Inspection Service.
[FR Doc. 2019–16580 Filed 8–1–19; 8:45 am]
BILLING CODE 3410–34–P

DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2019–0044]

Availability of an Environmental
Assessment for Field Testing of a
Pseudogymnoascus destructans
Vaccine, Live Raccoon Poxvirus
Vector (RCN–CAL/SP/ASPF2/PD–
ENG2)
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice.
AGENCY:

We are advising the public
that the Animal and Plant Health
Inspection Service has prepared an
environmental assessment concerning
authorization to ship for the purpose of
field testing, and then to field test, an
unlicensed Pseudogymnoascus
destructans Vaccine, Live Raccoon
Poxvirus Vector (RCN–CAL/SP/ASPF2/
PD–ENG2). The environmental
assessment, which is based on a risk
analysis prepared to assess the risks
associated with the field testing of this
vaccine, examines the potential effects
that field testing this veterinary vaccine
could have on the quality of the human
environment. Based on the risk analysis,
we have reached a preliminary
determination that field testing this
veterinary vaccine will not have a
significant impact on the quality of the
human environment, and that an
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environmental impact statement need
not be prepared. We intend to authorize
shipment of this vaccine for field testing
following the close of the comment
period for this notice unless new
substantial issues bearing on the effects
of this action are brought to our
attention. We also intend to issue a U.S.
Veterinary Biological Product license for
this vaccine, provided the field test data
support the conclusions of the
environmental assessment and the
issuance of a finding of no significant
impact and the product meets all other
requirements for licensing.
DATES: We will consider all comments
that we receive on or before September
3, 2019.
ADDRESSES: You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
http://www.regulations.gov/#!docket
Detail;D=APHIS-2019-0044.
• Postal Mail/Commercial Delivery:
Send your comment to Docket No.
APHIS–2019–0044, Regulatory Analysis
and Development, PPD, APHIS, Station
3A–03.8, 4700 River Road Unit 118,
Riverdale, MD 20737–1238.
Supporting documents and any
comments we receive on this docket
may be viewed at http://
www.regulations.gov/#!docketDetail;
D=APHIS-2019-0044 or in our reading
room, which is located in Room 1141 of
the USDA South Building, 14th Street
and Independence Avenue SW,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 7997039 before coming.
FOR FURTHER INFORMATION CONTACT: Dr.
Barbara J. Sheppard, Senior Staff
Veterinary Medical Officer, Center for
Veterinary Biologics, Policy, Evaluation,
and Licensing, VS, APHIS, 1920 Dayton
Avenue, Ames, IA 50010; phone (515)
337–6100; fax (515) 337–6120.
For information regarding the
environmental assessment or the risk
analysis, or to request a copy of the
environmental assessment (as well as
the risk analysis with confidential
business information removed), contact
Dr. Mathew Erdman, Senior Staff
Veterinary Medical Officer, Center for
Veterinary Biologics, Policy, Evaluation,
and Licensing VS, APHIS, 1920 Dayton
Avenue, P.O. Box 844, Ames, IA 50010;
phone (515) 337–6100; fax (515) 337–
6120.
SUPPLEMENTARY INFORMATION: Under the
Virus-Serum-Toxin Act (21 U.S.C. 151
et seq.), a veterinary biological product
must be shown to be pure, safe, potent,
and efficacious before a veterinary
biological product license may be
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issued. A field test is generally
necessary to satisfy prelicensing
requirements for veterinary biological
products. Prior to conducting a field test
on an unlicensed product, an applicant
must obtain approval from the Animal
and Plant Health Inspection Service
(APHIS), as well as obtain APHIS’
authorization to ship the product for
field testing.
To determine whether to authorize
shipment and grant approval for the
field testing of the unlicensed product
referenced in this notice, APHIS
conducted a risk analysis to assess the
potential effects of this product on the
safety of animals, public health, and the
environment. Based on the risk analysis,
APHIS has prepared an environmental
assessment (EA) concerning the field
testing of the following unlicensed
veterinary biological product:
Requester: U.S. Geological Survey,
National Wildlife Health Center.
Product: Pseudogymnoascus
destructans Vaccine, Live Raccoon
Poxvirus Vector (RCN–CAL/SP/ASPF2/
PD–ENG2).
Possible Field Test Locations:
Colorado, Iowa, Minnesota, Nebraska,
Oklahoma, Texas, or Wisconsin, among
others.
The above-mentioned product
consists of a live recombinant raccoon
poxvirus vector expressing four
Pseudogymnoascus destructans
proteins. The vaccine is for the oral
vaccination of bats as an aid in the
prevention and control of White-Nose
Syndrome.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provisions
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
Unless substantial issues with adverse
environmental impacts are raised in
response to this notice, APHIS intends
to issue a finding of no significant
impact (FONSI) based on the EA and
authorize shipment of the above product
for the initiation of field tests following
the close of the comment period for this
notice.
Because the issues raised by field
testing and by issuance of a license are
identical, APHIS has concluded that the
EA that is generated for field testing
would also be applicable to the
proposed licensing action. Provided that
the field test data support the
conclusions of the original EA and the
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